Paper41219086
Post-translational modifications of NLRP3: to prime or not to prime?
Dufies O and 1 other. Trends Immunol, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Post-translational modifications of NLRP3: to prime or not to prime? Papers, record 41219086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41219086
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Processing, Post-Translational | Major topic |
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Inflammasomes | Major topic |
| Humans | |
| Animals | |
| Signal Transduction | |
| Inflammation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI170632 | NIAID NIH HHS | United States | R01AI170632 | PubMed |
Source NIH RePORTER
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36127465 | How location and cellular signaling combine to activate the NLRP3 inflammasome. | Cell Mol Immunol | 2022 | https://conductscience.org/library/papers/36127465 | PubMed |
| 2 | 27548431 | NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. | Nat Immunol | 2016 | https://conductscience.org/library/papers/27548431 | PubMed |
| 3 | 26611636 | Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. | Cell Res | 2015 | https://conductscience.org/library/papers/26611636 | PubMed |
| 4 | 15030775 | NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. | Immunity | 2004 | https://conductscience.org/library/papers/15030775 | PubMed |
| 5 | 37198476 | Structural basis of NINJ1-mediated plasma membrane rupture in cell death. | Nature | 2023 | https://conductscience.org/library/papers/37198476 | PubMed |
| 6 | 31895698 | Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis. | J Clin Invest | 2020 | https://conductscience.org/library/papers/31895698 | PubMed |
| 7 | 37781816 | BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis. | Circulation | 2023 | https://conductscience.org/library/papers/37781816 | PubMed |
| 8 | 34554188 | BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity. | J Exp Med | 2021 | https://conductscience.org/library/papers/34554188 | PubMed |
| 9 | 20835230 | Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20835230 | PubMed |
| 10 | 30046112 | New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. | Nature | 2018 | https://conductscience.org/library/papers/30046112 | PubMed |
| 11 | 16301671 | Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. | J Immunol | 2005 | https://conductscience.org/library/papers/16301671 | PubMed |
| 12 | 29599418 | New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). | J Med Genet | 2018 | https://conductscience.org/library/papers/29599418 | PubMed |
| 13 | 33691097 | Itaconate confers tolerance to late NLRP3 inflammasome activation. | Cell Rep | 2021 | https://conductscience.org/library/papers/33691097 | PubMed |
| 14 | 36178239 | TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization. | EMBO Rep | 2022 | https://conductscience.org/library/papers/36178239 | PubMed |
| 15 | 21484785 | Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. | Eur J Immunol | 2011 | https://conductscience.org/library/papers/21484785 | PubMed |
| 16 | 38266638 | Serine synthesis sustains macrophage IL-1β production via NAD+-dependent protein acetylation. | Mol Cell | 2024 | https://conductscience.org/library/papers/38266638 | PubMed |
| 17 | 34518217 | TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34518217 | PubMed |
| 18 | 39187689 | Gasdermins as evolutionarily conserved executors of inflammation and cell death. | Nat Cell Biol | 2024 | https://conductscience.org/library/papers/39187689 | PubMed |
| 19 | 37651190 | Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37651190 | PubMed |
| 20 | 39116210 | FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation. | Cell Rep | 2024 | https://conductscience.org/library/papers/39116210 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923166 | The NLRP3 inflammasome as a bridge between myocardial infarction and depression: mechanisms, bidirectional link, and therapeutic potential. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42923166 | PubMed |
| 42889843 | Metal-Organic Framework-Based Nanomedicine for Sepsis Therapy: From Microenvironment Regulation to Precision Therapeutic Strategies. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42889843 | PubMed |
| 42732341 | Tissue-Resident Macrophage in Inflammation and Cancer. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42732341 | PubMed |
| 42650883 | The Role of Skeletal Muscle Mitochondria in NLRP3 Inflammasome Signaling. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650883 | PubMed |
| 42464297 | The NLRP3 inflammasome in gastrointestinal malignancies: molecular mechanisms, regulatory networks, and therapeutic opportunities. | J Transl Med | 2026 | https://conductscience.org/library/papers/42464297 | PubMed |
| 42278349 | Mitochondrial Regulation of the NLRP3 Inflammasome in Diabetic Kidney Disease: From Mechanisms to Therapeutic Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278349 | PubMed |
| 41879501 | Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis. | Bioessays | 2026 | https://conductscience.org/library/papers/41879501 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP1 | 834 | PubTator's text mining | https://conductscience.org/library/genes/834 | NCBI Gene |
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41219086
GET https://conductscience.org/api/papers/v1/41219086/references?page=2